# Dynamic Drug Discovery

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dynamic-drug-discovery

- Industry: Pharmaceuticals
- Headquarters: Daejeon-City, South Korea
- Total disclosed funding: $0.1M
- Latest round: Seed (Oct 31, 2022)
- Investors on record: 1

## About

Based in Daejeon, South Korea, and founded in 2022, Dynamic Drug Discovery formerly known as Dementia Drug Discovery, operates as a pharmaceutical company that develops DAPPD, a drug treatment. In January 2024, Dynamic Drug Discovery raised KRW 1.5 billion in pre-series A funding from returning investor Vine Ventures.

Dynamic Drug Discovery develops DAPPD for neuroinflammation-modified Tylenol's structure to cross the blood-brain barrier.

## Funding rounds

- Seed, Oct 31, 2022, $0.1M — Vine Ventures

## Investors

- Vine Ventures — Seed